C-peptide increase in chronic type 1 diabetic patients treated with autologous bone marrow cell transplantation through pancreatic artery catheterization: Three years follow-up

ISSN Print: 2161-6760
ISSN Online: 2161-6787
www.scirp.net/journal/scd
E-mail: [email protected]

Citations

"C-peptide increase in chronic type 1 diabetic patients treated with autologous bone marrow cell transplantation through pancreatic artery catheterization: Three years follow-up"
written by Alejandro Mesples, Shu Jiang, Yun Zhang, Zhaoxia Luo, Xiang Hu,
published by Stem Cell Discovery, Vol.3 No.1, 2013

has been cited by the following article(s):

[1]	Long Term Benefit of Autologous Bone Marrow Stem Cell Transplantation without Immunosuppression in Chronic Type 1 Diabetic Patients
	2020

[2]	Engineering a Clinically Translatable Bioartificial Pancreas to Treat Type I Diabetes
	Trends in Biotechnology, 2018

[3]	Stem Cell Research and Regenerative Medicine
	2018

[4]	Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus
	Endocrine Pathology, 2015

[1]	Long Term Benefit of Autologous Bone Marrow Stem Cell Transplantation without Immunosuppression in Chronic Type 1 Diabetic Patients Stem Cell Discovery, 2020 DOI:10.4236/scd.2020.101001

[2]	Engineering a Clinically Translatable Bioartificial Pancreas to Treat Type I Diabetes Trends in Biotechnology, 2018 DOI:10.1016/j.tibtech.2018.01.007

[3]	Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus Endocrine Pathology, 2015 DOI:10.1007/s12022-015-9362-y

Top